Internal Medicine, Hematology & Oncology · Frederick, MD
NPI
1891134466
Since 2013
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1562 Opossumtown Pike
Frederick, MD, 21702
Phone (301) 662-8477
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
110,029 services
Medicare patients, 2024
650
Average age 74
Drug cost, 2024
$1.8M
682 prescriptions
Company payments, 2025
$43.25
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Natalia Marina was code J9271 (injection, pembrolizumab, 1 mg), 8,000 times for 19 patients. In total Natalia Marina billed 110,029 services in 146 codes, and Medicare paid $2.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 8,000 | 19 | $36.91 | $295K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 5,850 | 18 | $0.11 | $667 |
| J1756 Injection, iron sucrose, 1 mg | Office | 5,700 | 13 | $0.18 | $1,018 |
| J0897 Injection, denosumab, 1 mg | Office | 4,260 | 51 | $19.80 | $84K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2,150 | 14 | $35.05 | $75K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,318 | 63 | $0.09 | $115 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,240 | 61 | $0.13 | $166 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 452 | 14 | $3.41 | $1,541 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 321 | 198 | $13.04 | $4,186 |
| 99214 Office E&M - Established | Office | 225 | 165 | $96.52 | $22K |
| 96375 Injection Administration | Office | 218 | 77 | $12.24 | $2,669 |
| 96413 Chemotherapy Administration | Office | 206 | 103 | $102.79 | $21K |
| J9190 Injection, fluorouracil, 500 mg | Office | 163 | 17 | $2.38 | $387 |
| 96372 Injection Administration | Office | 161 | 107 | $11.32 | $1,823 |
| 99215 Office E&M - Established | Office | 151 | 74 | $140.56 | $21K |
By year: 2022 $2.6M for 170,162 services; 2023 $2.3M for 156,021 services; 2024 $2.1M for 110,029 services.
Medicare prescription drug claims, 2024
In 2024, the drug Natalia Marina prescribed most often to Medicare patients was Letrozole, with 172 prescriptions and refills. In total Natalia Marina wrote 682 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 172 | 434 | 60 | $4,943 |
| Anastrozole Generic | 90 | 254 | 43 | $2,147 |
| Eliquis Apixaban | 71 | 81 | 15 | $47K |
| Tamoxifen Citrate Generic | 30 | 90 | 13 | $766 |
| Dexamethasone Generic | 24 | 30 | 12 | $249 |
| Revlimid Lenalidomide | 22 | 22 | Under 11 | $367K |
| Orserdu Elacestrant Hcl | 21 | 21 | Under 11 | $490K |
| Lenalidomide Generic | 21 | 21 | Under 11 | $221K |
| Prochlorperazine Maleate Generic | 16 | 16 | 15 | $210 |
| Verzenio Abemaciclib | 15 | 15 | Under 11 | $222K |
| Raloxifene Hcl Generic | 14 | 42 | Under 11 | $701 |
| Hydroxyurea Generic | 14 | 29 | Under 11 | $284 |
| Ondansetron Odt Ondansetron | 14 | 15 | Under 11 | $236 |
| Ondansetron Hcl Generic | 12 | 12 | Under 11 | $114 |
| Exemestane Generic | 11 | 33 | Under 11 | $4,598 |
Brand drugs: 156 claims; generic drugs: 526 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Natalia Marina $43.25 ($43.25 in general payments such as food, travel and fees) from 1 company. The largest payer was AstraZeneca Pharmaceuticals LP with $43.25.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $43.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.